Eye implant conveying equipment and using method thereof
By integrating the needle receiving mechanism in the eye implant delivery device, the problem of needle exposure after injection is solved, the risk of injury and cross-infection is reduced, and the safety of the delivery process is improved.
Patent Information
- Application Number
- CN202411345145.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-25
- Publication Date
- 2024-11-08
AI Technical Summary
Existing eye implant delivery devices are prevalent after injection, increasing the risk of injury to healthcare workers and patients and may lead to cross infection.
An eye implant delivery device with integrated needle receiving mechanism is designed. After injection is completed, the needle can be put into the pen assembly. Through the control of the needle receiving mechanism, the needle is avoided and the operation safety is improved.
It effectively reduces the risk of accidental stabbing in medical staff and patients, reduces the possibility of cross-infection caused by needle contamination, and improves the safety of the delivery process of eye implants.
Smart Images

Figure CN118902736A_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of medical device technology, and in particular to an eye implant delivery device and its method of use. Background Technology
[0002] In the field of ophthalmic treatment, precise delivery of ocular implants is crucial to ensure that drugs or therapeutic implants are safely and accurately delivered to specific locations within the eye. While existing delivery devices meet these requirements to some extent, they often neglect operational safety in their design.
[0003] Existing ocular implant delivery devices often neglect the safe disposal of needles after injection. While some devices possess basic injection capabilities, they are significantly inadequate in needle retrieval after the procedure. In particular, needle protrusion is common after injection, increasing the risk of injury to healthcare workers and patients, and potentially leading to cross-infection and other medical safety issues. Therefore, it is necessary to develop an ocular implant delivery device with improved safety features to enhance operational safety. Summary of the Invention
[0004] The purpose of this application is to provide an ocular implant delivery device that effectively solves the problem of needle protrusion after injection by integrating a needle retraction mechanism into the pen assembly, reducing the risk of injury to medical staff and patients, decreasing the possibility of cross-infection, and improving the safety of the ocular implant delivery process. Another purpose of this application is to provide a method of using the ocular implant delivery device.
[0005] To achieve the above objectives, this application provides an ocular implant delivery device, comprising:
[0006] Pen component;
[0007] A needle is provided in the pen assembly, the needle being used to receive an ocular implant;
[0008] An injection mechanism is provided on the pen assembly, the injection mechanism being used to push the ocular implant out of the needle to deliver the ocular implant;
[0009] A needle retraction mechanism is provided on the pen assembly. The needle retraction mechanism is connected to the needle tip and is used to control the needle tip to retract into the pen assembly.
[0010] In some embodiments, the needle tip is provided with a connected needle tube and a connector, the connector being provided with a first connector and a second connector, the first connector being connected to the pen assembly, and the second connector being connected to the needle retraction mechanism;
[0011] When the needle retraction mechanism controls the movement of the needle, the force exerted by the pen assembly on the first connector is less than the force exerted by the needle retraction mechanism on the second connector.
[0012] In some embodiments, the pen assembly includes a front cone having a through hole, a groove, and a slot; the needle retraction mechanism includes a needle retraction sleeve having grippers.
[0013] The needle tube extends through the through hole;
[0014] The first connector includes a first protrusion and a second protrusion, the first protrusion engaging with the slide groove and the second protrusion engaging with the slot.
[0015] The second connector includes a third protrusion that engages with the gripper.
[0016] When the needle retractor controls the needle tube to retract from the through hole to the front cone, the force exerted by the slot on the second protrusion is less than the force exerted by the gripper on the third protrusion.
[0017] In some embodiments, the number of third protrusions is two, and the two third protrusions are disposed at both ends of the first diagonal of the connector, the first protrusion and the second protrusion are disposed at both ends of the second diagonal of the connector, and the first diagonal and the second diagonal are perpendicular.
[0018] In some embodiments, the needle retractor is further provided with an operating cap located at the distal end of the pen assembly, the operating cap being used to control the gripper to move the needle tip.
[0019] In some embodiments, the needle retractor sleeve further comprises a cylinder, the proximal end of which is connected to the gripper, and the distal end of which is connected to the operating cap, the cylinder being located within the pen assembly.
[0020] In some embodiments, the injection mechanism includes:
[0021] A trigger component is located on the pen component;
[0022] An action component is provided in the pen assembly, the action component is located in the needle retraction mechanism, the action component is movable in the needle retraction mechanism, and the action component is used to eject the ocular implant from the needle under the control of the triggering component.
[0023] In some embodiments, the needle take-up mechanism includes a needle take-up sleeve, the needle take-up sleeve having a support arm, the support arm having a gripper and a limiting portion; the actuation component is disposed in the needle take-up sleeve, the actuation component including:
[0024] The push rod has a connected ejector pin and a movable seat. The ejector pin passes through the needle tip, and the movable seat is located on the support arm. The movable seat can move in the support arm. The distal end of the push rod is restricted by the limiting part, and the range of motion of the movable seat is restricted by the gripper.
[0025] The triggering component is used to control the pin portion to push the eye implant out of the needle.
[0026] In some embodiments, the push rod further includes a deformation mechanism connected to the movable seat; the triggering component includes:
[0027] An injection button is located on the pen assembly. Pressing the injection button compresses the deformation mechanism, causing the pin portion to push the eye implant out of the needle.
[0028] In some embodiments, the needle includes a needle tube with a needle tube notch; the ocular implant delivery device further includes:
[0029] A cannula, fitted onto the needle tube, is positionally adjustable on the needle tube; the cannula is made of an elastic material, and the cannula covers the notch of the needle tube, entering the notch of the needle tube under its own elasticity to fix the ocular implant in the needle tube. In some embodiments, the pen assembly includes:
[0030] Pen body;
[0031] A front cone is located at the proximal end of the pen cap;
[0032] The pen cap is detachably connected to the pen body and / or the front cone.
[0033] The needle is located on the pen body and extends out from the front cone.
[0034] In some embodiments, the pen body is provided with an anti-slip structure; and / or,
[0035] The pen body has an irregularly shaped hole; the injection mechanism includes an injection button, which is located in the irregularly shaped hole; and / or...
[0036] The front cone is provided with a mating flange; the pen cap is interference-fitted with the mating flange.
[0037] In some embodiments, the ocular implant delivery device further includes:
[0038] A protective component is provided on the pen assembly. The protective component is movable. When the protective component is moved to a first position, it locks the injection mechanism. When the protective component is moved to a second position, it releases the injection mechanism.
[0039] The injection mechanism includes an injection button and a push rod, and the protective component locks and releases the injection button and / or the push rod.
[0040] In some embodiments, the pen assembly includes a pen body with perforations; the movable seat of the push rod has a positioning hole; and the injection button has a positioning groove.
[0041] The protective component includes a safety pull ring, which has a limiting protrusion and a limiting protrusion. The limiting protrusion is located on the radial side of the limiting protrusion. The limiting protrusion passes through the through hole and into the positioning hole to lock the push rod. The limiting protrusion is engaged in the positioning groove to lock the injection button.
[0042] This application also provides a method of using an ocular implant delivery device, applicable to the aforementioned ocular implant delivery device, the method of use comprising:
[0043] Step 1: Control the needle retraction mechanism to retract the needle into the pen assembly.
[0044] In some embodiments, step one specifically includes:
[0045] Pull the operating cap of the needle retraction sleeve to control the needle retraction sleeve to move away from the near end of the pen body. The gripper of the needle retraction sleeve drives the needle to move synchronously, so that the needle tube of the needle retracts into the front cone at the near end of the pen body, and further retracts into the pen body, thus realizing the needle retraction operation.
[0046] In some embodiments, the method of using the ocular implant delivery device further includes:
[0047] Step two: First, twist the safety pull ring so that the limiting protrusion of the safety pull ring moves out of the positioning groove of the injection button. Then, pull the safety pull ring so that the limiting protrusion of the safety pull ring is pulled out of the positioning hole of the movable seat, and further out of the perforation to be pulled out of the pen body, thus realizing the unlocking operation.
[0048] Compared with the above-mentioned background technology, the ocular implant delivery device provided in this application mainly includes a pen assembly, a needle, an injection mechanism, and a needle retraction mechanism. The needle is located in the pen assembly and is used to contain the ocular implant. The injection mechanism is located in the pen assembly and is used to push the ocular implant out of the needle to realize the delivery of the ocular implant. The needle retraction mechanism is located in the pen assembly and is connected to the needle. The needle retraction mechanism is used to control the needle to be retracted into the pen assembly.
[0049] In traditional ocular implant delivery devices, needle protrusion after injection is a common problem. This not only increases the risk of injury to medical staff and patients during the procedure but also may lead to cross-infection in the medical environment. To address this issue, the ocular implant delivery device provided in this application features an innovative design, the core improvement of which lies in the integration of a needle retraction mechanism.
[0050] The needle retraction mechanism is connected to the needle in the pen assembly, enabling control of the needle's retraction into the pen assembly after the injection procedure. This design directly addresses the shortcomings of existing technologies where the needle is exposed, fundamentally avoiding the safety hazards associated with exposed needles by retracting the needle into the pen body. First, with the needle retracted into the pen body, medical staff and patients will not directly contact the needle when operating the device, greatly reducing the risk of accidental needle sticks. Second, since the needle is no longer exposed, the chance of contact with the external environment is reduced, which helps to reduce cross-infection problems caused by needle contamination.
[0051] Based on the above structural and process descriptions, it can be seen that the eye implant delivery device has at least the following beneficial effects: by integrating the needle retraction mechanism into the pen assembly, the eye implant delivery device effectively solves the problem of needle protrusion after injection, reduces the risk of injury to medical staff and patients, reduces the possibility of cross-infection, and improves the safety of the eye implant delivery process. Attached Figure Description
[0052] To more clearly illustrate the technical solutions in the embodiments of this application or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of this application. For those skilled in the art, other drawings can be obtained based on the provided drawings without creative effort.
[0053] Figure 1 This is a schematic diagram of the first state of the ocular implant delivery device provided in the embodiments of this application;
[0054] Figure 2 This is a schematic diagram of the second state of the ocular implant delivery device provided in the embodiments of this application;
[0055] Figure 3 This is a schematic diagram of the third state of the ocular implant delivery device provided in the embodiments of this application;
[0056] Figure 4 A schematic diagram of a needle provided in an embodiment of this application;
[0057] Figure 5 A schematic diagram of the needle and pen assembly provided in an embodiment of this application;
[0058] Figure 6 A schematic diagram of the needle and needle retraction mechanism provided in the embodiments of this application;
[0059] Figure 7 A schematic diagram of the needle receiving mechanism provided in an embodiment of this application;
[0060] Figure 8 A schematic diagram of the injection mechanism provided in an embodiment of this application;
[0061] Figure 9 A schematic diagram of the motion component provided in an embodiment of this application;
[0062] Figure 10 A schematic diagram of the push rod and the needle take-up sleeve provided in the embodiments of this application;
[0063] Figure 11 A schematic diagram of the needle and cannula provided in the embodiments of this application;
[0064] Figure 12 An exploded view of the ocular implant delivery device provided in the embodiments of this application;
[0065] Figure 13 A schematic diagram of the pen body provided for an embodiment of this application;
[0066] Figure 14 A schematic diagram of the anterior cone provided in an embodiment of this application;
[0067] Figure 15 A schematic diagram of a safety pull ring provided in an embodiment of this application;
[0068] Figure 16 A schematic diagram of the injection button provided in an embodiment of this application;
[0069] Figure 17 A schematic diagram of the safety pull ring and injection button provided in the embodiments of this application;
[0070] Figure 18 A cross-sectional view of an ocular implant delivery device provided in an embodiment of this application.
[0071] in:
[0072] Pen assembly 1, pen body 11, perforation 111, anti-slip structure 112, irregular hole 113, front cone 12, through hole 121, sliding groove 122, slot 123, mating flange 124, pen cap 13.
[0073] Needle 2, needle tube 21, needle tube notch 211, connector 22, first connector 221, first protrusion 2211, second protrusion 2212, second connector 222, third protrusion 2221.
[0074] Eye implants 3
[0075] Injection facility 4
[0076] Trigger component 41, injection button 411, pressing block 4111, positioning groove 41111, limit platform 4112, force transmission block 4113
[0077] Action component 42, push rod 421, ejector pin 4211, movable seat 4212, positioning hole 42121, deformation mechanism 4213, positioning seat 4214
[0078] Needle retraction mechanism 5, needle retraction sleeve 51, gripper 511, support arm 512, side arm 5121, bottom arm 5122, limiting part 513, cylinder 514, operating cap 515.
[0079] Protective component 6, safety pull ring 61, limit protrusion 611, limit protrusion 612, control handle 613
[0080] Sleeve 7. Detailed Implementation
[0081] The technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. Based on the embodiments of this application, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this application.
[0082] To enable those skilled in the art to better understand the present application, the present application will be further described in detail below with reference to the accompanying drawings and specific embodiments.
[0083] Please refer to Figures 1 to 3 ,in, Figure 1 This is a schematic diagram of the first state of the ocular implant delivery device provided in an embodiment of this application. Figure 2 This is a schematic diagram of the second state of the ocular implant delivery device provided in an embodiment of this application. Figure 3 This is a schematic diagram of the third state of the ocular implant delivery device provided in the embodiments of this application.
[0084] It should be noted that, in this application, the proximal end refers to the direction close to the needle 2, i.e., towards the injection site, with the ocular implant delivery device as the reference object; the distal end refers to the direction opposite to the proximal end, i.e., away from the injection site.
[0085] In a first specific embodiment, the ocular implant delivery device provided by the present application mainly includes a pen assembly 1, a needle 2, an injection mechanism 4, and a needle retraction mechanism 5. The needle 2 is disposed on the pen assembly 1 and is used to accommodate the ocular implant 3. The injection mechanism 4 is disposed on the pen assembly 1 and is used to push the ocular implant 3 out from the needle 2 to realize the delivery of the ocular implant 3. The needle retraction mechanism 5 is disposed on the pen assembly 1 and is connected to the needle 2. The needle retraction mechanism 5 is used to control the needle 2 to be retracted into the pen assembly 1.
[0086] contrast Figure 2 and Figure 3 As you can see, Figure 2 The eye implant delivery device can deliver the eye implant 3, at which time the needle 2 is exposed outside the pen assembly 1; Figure 3 After the eye implant delivery device completes the delivery of the eye implant 3, the needle 2 is retracted into the pen assembly 1 under the control of the needle retraction mechanism 5.
[0087] In traditional ocular implant delivery devices, needle 2 protrusion after injection is a common problem, which not only increases the risk of injury to medical staff and patients during the procedure, but may also lead to cross-infection in the medical environment. To address this issue, the ocular implant delivery device provided in this application features an innovative design, the core improvement of which lies in the integration of a needle retraction mechanism 5.
[0088] The needle retraction mechanism 5 is connected to the needle 2 in the pen assembly 1, enabling it to retract the needle 2 into the pen assembly 1 after the injection operation is completed. This design directly addresses the defect of exposed needle 2 in existing technologies, fundamentally avoiding the safety hazards caused by exposed needle 2 by retracting it into the pen body 11. First, when the needle 2 is retracted into the pen body 11, medical staff and patients will not directly contact the needle 2 when operating the device, thus greatly reducing the risk of accidental needle stick injuries. Second, since the needle 2 is no longer exposed, the chance of contact with the external environment is reduced, which helps to reduce the problem of cross-infection caused by needle 2 contamination.
[0089] Based on the above structural and process descriptions, it can be seen that the eye implant delivery device has at least the following beneficial effects: by integrating the needle receiving mechanism 5 into the pen assembly 1, the eye implant delivery device effectively solves the problem of needle 2 protrusion after injection, reduces the risk of injury to medical staff and patients, reduces the possibility of cross-infection, and improves the safety of the eye implant delivery process.
[0090] It should be noted that this embodiment does not limit the control method of the needle head 2 by the needle take-up mechanism 5. For example, the needle take-up mechanism 5 can pull the needle head 2 to change its axial position. In this way, the needle take-up mechanism 5 can directly provide a pulling action to the needle head 2, or it can be combined with an elastic element. By changing the degree of deformation of the elastic element, the elastic element can provide an elastic effect on the needle head 2. Alternatively, the rotational motion can be converted into the linear motion of the needle head 2 through threaded engagement or other methods. In addition, the number of parts of the needle take-up mechanism 5 may include, but is not limited to, one or more, and the position of the needle take-up mechanism 5 may include, but is not limited to, the axial direction of the needle head 2 and the axial side of the needle head 2. As long as the control of the needle head 2 by the needle take-up mechanism 5 can be achieved, it should also fall within the scope of this application.
[0091] Please refer to Figures 4 to 6 ,in, Figure 4 This is a schematic diagram of a needle provided in an embodiment of this application. Figure 5 This is a schematic diagram of the needle and pen assembly provided in an embodiment of this application. Figure 6 This is a schematic diagram of the needle and needle retraction mechanism provided in an embodiment of this application.
[0092] In some embodiments, the needle 2 is provided with a connected needle tube 21 and a connector 22. The connector 22 is provided with a first connector 221 and a second connector 222. The first connector 221 is connected to the pen assembly 1, and the second connector 222 is connected to the needle retraction mechanism 5. When the needle retraction mechanism 5 controls the needle 2 to move, the force exerted by the pen assembly 1 on the first connector 221 is less than the force exerted by the needle retraction mechanism 5 on the second connector 222.
[0093] In this embodiment, the needle 2 is designed to include a needle tube 21 and a connector 22, wherein the connector 22 is constructed with two key parts: a first connector 221 and a second connector 222. The first connector 221 is connected to the pen assembly 1 to maintain the correct position of the needle 2 within the pen assembly 1, such as axial and radial stability. The second connector 222 is connected to the needle retraction mechanism 5, and this connection plays a crucial role in the needle retraction operation.
[0094] When the needle retraction mechanism 5 operates, the force it exerts on the second connector 222 is crucial for controlling the retraction of the needle tip 2. When the needle retraction mechanism 5 actuates, the force it exerts on the second connector 222 is greater than the force exerted by the pen assembly 1 on the first connector 221. This design allows the needle retraction mechanism 5 to overcome the stabilizing effect of the pen assembly 1 on the needle tip 2 when needed, thereby achieving a smooth needle retraction action.
[0095] In short, this mechanism ensures that the pen assembly 1 can stably maintain the position of the needle 2 under normal use, and when a needle retraction operation is required, the needle retraction mechanism 5 can release the needle 2 and safely retract it into the pen assembly 1, thereby ensuring the safety and convenience of operation.
[0096] Please continue to refer to this. Figure 5 and Figure 6 In some embodiments, the pen assembly 1 includes a front cone 12, which has a through hole 121, a sliding groove 122, and a retaining groove 123; the needle retraction mechanism 5 includes a needle retraction sleeve 51, which has a gripper 511; the needle tube 21 extends through the through hole 121; the first connecting body 221 includes a first protrusion 2211 and a second protrusion 2212, the first protrusion 2211 cooperating with the sliding groove 122, and the second protrusion 2212 cooperating with the retaining groove 123; the second connecting body 222 includes a third protrusion 2221, which cooperates with the gripper 511; when the needle retraction sleeve 51 controls the needle tube 21 to retract from the through hole 121 back to the front cone 12, the force exerted by the retaining groove 123 on the second protrusion 2212 is less than the force exerted by the gripper 511 on the third protrusion 2221.
[0097] In this embodiment, the pen assembly 1 specifically includes a front cone 12, which has a through hole 121, a groove 122, and a slot 123, all of which play an important role. The through hole 121 of the front cone 12 allows the needle tube 21 to pass through, ensuring that the needle 2 can work in conjunction with the pen assembly 1 while maintaining the correct position and orientation.
[0098] The needle retraction mechanism 5 consists of a needle retraction sleeve 51, which has a gripper 511 for interacting with the connector 22 of the needle tip 2 during the needle retraction process. The design of the gripper 511 allows it to engage with the third protrusion 2221 on the second connector 222, and this engagement is key to achieving the needle retraction action.
[0099] The first connector 221 consists of a first protrusion 2211 and a second protrusion 2212. The first protrusion 2211 engages with the slide groove 122, where it is radially limited. The second protrusion 2212 engages with the retaining groove 123, which has an additional pair of protrusions compared to the slide groove 122. In this case, the second protrusion 2212 is simultaneously axially and radially limited. This design allows the first connector 221 to stably fix the needle 2 within the pen assembly 1, while allowing it to move when needed.
[0100] During the needle retraction operation, the retraction sleeve 51 controls the needle tube 21 to retract from the through hole 121 into the front cone 12. At this time, the force exerted by the slot 123 on the second protrusion 2212 is designed to be less than the force exerted by the gripper 511 on the third protrusion 2221. This imbalance of forces is intentional, ensuring that when the retraction sleeve 51 is pulled, the second connector 222 can overcome the interaction between the first connector 221 and the front cone 12, thereby allowing the needle tip 2 to be smoothly retracted into the pen assembly 1, completing the needle retraction action. This design not only ensures the smoothness of the needle retraction process but also improves the safety and reliability of the entire ocular implant delivery device.
[0101] Optionally, there are two third protrusions 2221, which are disposed at both ends of the first diagonal of the connector 22, and the first protrusion 2211 and the second protrusion 2212 are disposed at both ends of the second diagonal of the connector 22, with the first diagonal and the second diagonal perpendicular to each other.
[0102] In this embodiment, two third protrusions 2221 are designed. This configuration is intended to provide better force balance and stability during the operation of the needle take-up mechanism 5. These two third protrusions 2221 are symmetrically arranged at both ends of the first diagonal of the connector 22. This diagonal arrangement helps to evenly distribute the force during needle take-up and reduce stress concentration caused by a single point of force.
[0103] The first protrusion 2211 and the second protrusion 2212 are respectively disposed at both ends of the second diagonal of the connector 22, forming a perpendicular layout with the third protrusion 2221. This design not only ensures the stability of the needle 2 within the pen assembly 1, but also maintains the balance of force during needle retraction. When the needle retraction sleeve 51 acts on either of the third protrusions 2221 through the gripper 511, the third protrusion 2221 at the other end, as well as the opposing first protrusion 2211 and second protrusion 2212, can work together to ensure the stability of the entire system under force.
[0104] Furthermore, the perpendicular intersection of the first and second diagonals facilitates a smooth movement trajectory during needle retraction, reducing any jamming or unevenness caused by force imbalances and ensuring that the needle 2 can be smoothly retracted into the pen assembly 1. This precise geometric layout and mechanical design improves the safety and efficiency of the entire ocular implant delivery device during operation.
[0105] Please refer to Figure 7 , Figure 7 This is a schematic diagram of the needle receiving mechanism provided in an embodiment of this application.
[0106] In some embodiments, the needle retractor 51 is further provided with an operation cap 515, which is located at the distal end of the pen assembly 1. The operation cap 515 is used to control the gripper 511 to drive the needle 2 to move.
[0107] In this embodiment, the design of the needle retraction sleeve 51 is further optimized to improve operational stability and user experience. The operation cap 515, a key component of the needle retraction sleeve 51, is located at the distal end of the pen assembly 1, making it the primary control point for the operator during needle retraction. The operation cap 515 may include a grippy groove design, which helps increase friction during operation, ensuring stable grip and control of the operation cap 515 even with wet hands or while wearing gloves.
[0108] By using the operating cap 515, the operator can apply force to the gripper 511, thereby driving the needle 2 to perform the required action. This design not only provides an intuitive operating method, but also reduces potential misoperations or slippage during operation by enhancing control, thus improving the safety and accuracy of the entire ocular implant delivery device.
[0109] Optionally, the needle retractor 51 is also provided with a cylinder 514, the proximal end of which is connected to the gripper 511, and the distal end of which is connected to the operating cap 515. The cylinder 514 is located in the pen assembly 1.
[0110] In this embodiment, the cylinder 514 is an important component of the needle retraction sleeve 51, designed to move freely within the pen assembly 1. This mobility of the cylinder 514 is key to achieving the retraction of the needle 2. The proximal end of the cylinder 514 is connected to the gripper 511, while the distal end is connected to the operating cap 515.
[0111] When performing the needle retraction operation, the operator pulls the retraction sleeve 51. This action is transmitted through the cylinder 514, causing the gripper 511 to move accordingly. Since the cylinder 514 is connected to the gripper 511, the gripper 511 will drive the third protrusion 2221 connected to the second connector 222, thereby controlling the retraction of the needle 2. The distal end of the cylinder 514 is connected to the operating cap 515, ensuring that the operator can easily apply force and feel the feedback during operation.
[0112] The cylindrical design 514 allows for direct and efficient force transmission, while also making the entire needle retraction mechanism 5 more compact and reliable. This design enables the pen assembly 1 to not only maintain the stable position of the needle 2 but also to perform the needle retraction operation quickly and accurately when needed, significantly improving the safety and ease of operation of the ocular implant delivery device.
[0113] Please refer to Figure 8 , Figure 8 This is a schematic diagram of the injection mechanism provided in an embodiment of this application.
[0114] In some embodiments, the injection mechanism 4 includes:
[0115] Trigger component 41 is set in pen component 1;
[0116] Action component 42 is located in pen component 1 and needle retraction mechanism 5. Action component 42 can move in needle retraction mechanism 5. Action component 42 is used to push eye implant 3 out of needle tip 2 under the control of trigger component 41.
[0117] In this embodiment, the injection mechanism 4 is designed to consist of two main parts: a trigger component 41 and an action component 42, both of which are located on the pen component 1. The trigger component 41 is the part that is directly operated by the operator to activate the injection mechanism 4, while the action component 42 is the part that actually pushes the eye implant 3 out of the needle 2.
[0118] The actuation component 42 is specifically designed to be located within the needle retraction mechanism 5 and to perform a pushing motion within the needle retraction mechanism 5. This layout allows the actuation component 42 to perform precise movements under the control of the trigger component 41, thereby pushing the ocular implant 3 out of the needle 2. The mobility of the actuation component 42 ensures the flexibility and accuracy of the injection process, while also making the entire injection mechanism 4 more compact and efficient.
[0119] It should be noted that this embodiment does not limit the control method of the trigger component 41 on the action component 42. For example, the movement in other directions can be converted into the linear movement of the action component 42 through the engagement of threads, inclined surfaces, etc. Or the trigger component 41 can directly control the action component 42 in the axial direction. This should also fall within the scope of this application.
[0120] Please refer to Figure 9 , Figure 9 A schematic diagram of the action component provided in an embodiment of this application.
[0121] In some embodiments, the needle receiving mechanism 5 includes a needle receiving sleeve 51, the needle receiving sleeve 51 having a support arm 512, the support arm 512 having a gripper 511 and a limiting part 513; an action component 42 is disposed in the needle receiving sleeve 51, and the action component 42 includes:
[0122] The push rod 421 is provided with a connected ejector pin part 4211 and a movable seat 4212. The ejector pin part 4211 passes through the needle 2. The movable seat 4212 is provided on the support arm 512 and can move in the support arm 512. The distal end of the push rod 421 is limited by the limiting part 513. The range of movement of the movable seat 4212 is limited by the gripper 511.
[0123] The trigger component 41 is used to control the pin part 4211 to push the eye implant 3 out of the needle 2.
[0124] In this embodiment, the needle receiving sleeve 51 is provided with a support arm 512, which is connected to the proximal end of the cylinder 514. The gripper 511 and the limiting part 513 are located at the proximal end and distal end of the support arm 512, respectively.
[0125] The actuation component 42 is cleverly housed within the needle retraction sleeve 51. It includes a push rod 421 having a pin portion 4211 and a movable seat 4212. The pin portion 4211 is the component that directly contacts the ocular implant 3 and pushes it out of the needle tip 2, while the movable seat 4212 is located on the support arm 512, allowing limited movement within the support arm 512.
[0126] The distal end of the push rod 421 is limited by the limiting part 513, which ensures precise control when pushing the ocular implant 3, while the range of motion of the movable seat 4212 is limited by the gripper 511. This design ensures the stability and accuracy of the actuation component 42 during injection operations.
[0127] The trigger component 41 is the operator-operated part, used to control the movement of the ejector pin 4211, thereby precisely ejecting the ocular implant 3 from the needle 2. The trigger component 41 may include an injection button or other forms of activation mechanism, which are connected to the action component 42 to ensure intuitive and responsive operation.
[0128] This integrated design not only enhances the functionality of the ocular implant delivery device but also optimizes the operator's experience, making the entire injection and needle removal process smoother and safer. Through the carefully designed needle removal mechanism 5 and motion assembly 42, this embodiment provides a reliable and efficient ocular implant delivery solution.
[0129] Please refer to Figure 10 , Figure 10 This is a schematic diagram of the push rod and the needle retractor provided in the embodiments of this application.
[0130] In some embodiments, the push rod 421 is further provided with a deformation mechanism 4213, which is connected to the movable seat 4212; the trigger assembly 41 includes:
[0131] An injection button 411 is located on the pen assembly 1. By pressing the injection button 411, the deformation mechanism 4213 is deformed, causing the needle part 4211 to push the eye implant 3 out of the needle 2.
[0132] In this embodiment, the design of the push rod 421 is further optimized by introducing a deformation mechanism 4213 to enhance its functionality. The deformation mechanism 4213 is connected to the movable seat 4212. This connection allows the movable seat 4212 to deform through the deformation mechanism 4213 when subjected to external force, thereby driving the ejector pin 4211.
[0133] One component of the trigger assembly 41 is the injection button 411, which is located on the pen assembly 1 for easy operation by the user. When the user presses the injection button 411, it transmits force to the deformation mechanism 4213, causing the deformation mechanism 4213 to deform. This deformation is crucial in the design because it translates into linear motion of the ejector pin 4211.
[0134] Specifically, the deformation of the deformation mechanism 4213 effectively pushes the ejector pin 4211 through the needle tip 2 and pushes the eye implant 3 out of the needle. Precise control of this process is achieved through the connection between the deformation mechanism 4213 and the movable seat 4212, ensuring that the eye implant 3 can be safely and accurately delivered to the designated position.
[0135] In some cases, the support arm 512 includes a pair of side arms 5121 and a bottom arm 5122. The proximal end of the side arms 5121 is provided with a gripper 511, and the distal end of the bottom arm 5122 is provided with a limiting part 513. The push rod 421 is limited on both sides by the pair of side arms 5121, and its bottom is limited by the bottom arm 5122, allowing the push rod 421 to move within the support arm 512. The proximal end of the push rod 421 is provided with a pin part 4211 and a movable seat 4212, and the distal end of the push rod 421 is provided with a positioning seat 4214. A deformation mechanism 4213 connects the movable seat 4212 and the positioning seat 4214. The forward movement distance of the movable seat 4212 is limited by the gripper 511, and the positioning seat 4214 abuts against the limiting part 513 rearward.
[0136] Optionally, the deformation mechanism 4213 has a snake-like structure, including multiple elastic plates connected one after another. When the injection button 411 squeezes the deformation mechanism 4213, the connection point of the elastic plates is pressed down, the included angle between the elastic plates increases, causing the deformation mechanism 4213 to extend, pushing the movable seat 4212 forward, and thus driving the ejector pin 4211 to achieve the pushing action.
[0137] Optionally, the injection button 411 includes a pressing block 4111, a limiting platform 4112, and a force transmission block 4113 connected sequentially from top to bottom. The surface of the pressing block 4111 is provided with an anti-slip structure, such as a groove, which increases the contact area and improves the friction to achieve an anti-slip effect. The positioning groove 41111 is located on the side of the pressing block 4111, allowing the pressing block 4111 to move within the irregular hole 113. The limiting platform 4112 is located within the pen body 11, and its size is larger than that of the irregular hole 113. The limiting platform 4112 abuts against the outer ring of the irregular hole 113, preventing the pressing block 4111 from dislodging from the irregular hole 113. The force transmission block 4113 exerts a squeezing effect on the deformation mechanism 4213.
[0138] Please refer to Figure 11 , Figure 11 This is a schematic diagram of the needle and cannula provided in the embodiments of this application.
[0139] In some embodiments, the needle 2 includes a needle tube 21, the needle tube 21 having a needle tube notch 211; the ocular implant delivery device further includes:
[0140] The cannula 7 is fitted onto the needle tube 21, and its position on the needle tube 21 is adjustable. The cannula 7 is made of elastic material and wraps around the needle tube notch 211. Under its own elasticity, the cannula 7 enters the needle tube notch 211 to fix the ocular implant 3 in the needle tube 21.
[0141] In this embodiment, the needle tube 21, a component of the needle 2, is designed with a needle tube notch 211. This design allows the cannula 7 to be tightly fitted over the outside of the needle tube 21. The cannula 7 serves multiple functions. First, made of an elastic material, the cannula 7 applies pressure to the internal ocular implant 3 by wrapping around the needle tube notch 211. This pressure helps maintain the stability of the ocular implant 3, preventing displacement or damage to its integrity due to vibration or other external factors. Furthermore, the adjustable position of the cannula 7 allows it to serve as an indicator of injection depth, which is crucial for ensuring that the ocular implant 3 is delivered to a specific location within the eye at the correct depth. By adjusting the position of the cannula 7, medical personnel can precisely control the injection depth, thereby improving the accuracy and safety of the treatment.
[0142] Please refer to Figure 12 , Figure 12 An exploded view of the ocular implant delivery device provided in the embodiments of this application.
[0143] In some embodiments, pen component 1 includes:
[0144] Pen body 11;
[0145] The front cone 12 is located near the end of the pen cap 13;
[0146] The pen cap 13 is detachably connected to the pen body 11 and / or the front cone 12;
[0147] The needle 2 is located on the pen body 11 and extends out from the front cone 12.
[0148] In this embodiment, the pen assembly 1 is designed with several key parts to achieve its structure and function. First, the pen body 11 constitutes the main body of the pen assembly 1, providing a foundation for support and connection to other components. A front cone 12 is provided at the proximal end of the pen body 11, and the pen cap 13 is connected to protect the front cone 12 and the needle 2 therein.
[0149] The pen cap 13 is designed to be detachably connected to the pen body 11 and / or the front cone 12. This design allows the operator to protect the needle 2 when the device is not in use, while also facilitating cleaning and maintenance. Furthermore, the detachable nature of the pen cap 13 provides a convenient way to quickly prepare the device for use when needed.
[0150] Please refer to Figure 13 , Figure 13 A schematic diagram of the pen body provided in an embodiment of this application.
[0151] In some embodiments, the pen body 11 is provided with an anti-slip structure 112.
[0152] In this embodiment, the pen body 11 is designed with an anti-slip structure 112, which increases the friction when gripping, ensuring that the operator can operate the device steadily even in wet or slippery conditions or when wearing gloves, thereby improving safety and accuracy during use.
[0153] In some embodiments, the pen body 11 is provided with an irregular hole 113; the injection mechanism 4 includes an injection button 411, which is located in the irregular hole 113.
[0154] In this embodiment, the pen body 11 is equipped with an irregularly shaped hole 113, whose special shape, such as an oval, provides precise positioning for the injection button 411. This design ensures that the injection button 411 can be securely mounted on the pen body 11, while making it easy for the operator to identify and operate, thus improving the accuracy of injection and the convenience of operation.
[0155] Please refer to Figure 14 , Figure 14 This is a schematic diagram of the anterior cone provided in an embodiment of this application.
[0156] In some embodiments, the front cone 12 is provided with a mating flange 124; the pen cap 13 is interference-fitted with the mating flange 124.
[0157] In this embodiment, the front cone 12 is designed with a mating flange 124, which achieves an interference fit with the pen cap 13. This fit means that when the pen cap 13 is installed on the front cone 12, the contact between the two is firm, ensuring that the pen cap 13 will not accidentally fall off or rotate during use, thereby maintaining the structural stability and operational reliability of the device. The design of the mating flange 124 enhances the overall tightness and durability of the pen assembly 1.
[0158] In one specific embodiment, the ocular implant delivery device further includes:
[0159] The protective component 6 is located on the pen component 1. The protective component 6 is movable. When the protective component 6 is moved to the first position, it locks the injection mechanism 4. When the protective component 6 is moved to the second position, it releases the injection mechanism 4.
[0160] The injection mechanism 4 includes an injection button 411 and a push rod 421. The protective component 6 locks and releases the injection button 411 and / or the push rod 421.
[0161] In this embodiment, the safety and operational control of the ocular implant delivery device are further enhanced by the introduction of the protective component 6. This protective component 6 is movable and is disposed on the pen assembly 1. Its function is to provide locking and releasing control of the injection mechanism 4 at different stages of device use.
[0162] Specifically, the protective component 6 can move to two different positions: a first position and a second position. When the protective component 6 is moved to the first position, it locks the injection mechanism 4, including the injection button 411 and / or the push rod 421. The locking mechanism ensures that the components of the injection mechanism 4 will not be accidentally moved or activated when the device is ready or during injection, thereby preventing possible misoperation or premature injection.
[0163] Conversely, when the protective component 6 moves to the second position, it releases the injection mechanism 4. This release action allows the operator to perform the injection operation. In this way, the protective component 6 not only improves the safety of the equipment but also provides precise control over the injection process.
[0164] contrast Figure 1 and Figure 2 As you can see, Figure 1 The eye implant delivery device is locked by the protective component 6, which can be regarded as the protective component 6 being in the first position; Figure 2 The eye implant delivery device is released by the protective component 6, which can be regarded as the protective component 6 being in the second position, and the eye implant 3 can be delivered.
[0165] It should be noted that this embodiment does not limit the structural form of the protective component 6. For example, the protective component 6 may be one or more parts, the protective component 6 may be a rotational action, a linear action or a combination of actions, the protective component 6 may be a part on the pen assembly 1 or a part that can be separated from the pen assembly 1, and all of these should fall within the scope of this application.
[0166] Please refer to Figures 15 to 17 ,in, Figure 15 This is a schematic diagram of a safety pull ring provided in an embodiment of this application. Figure 16 This is a schematic diagram of the injection button provided in an embodiment of this application. Figure 17 This is a schematic diagram of the safety pull ring and injection button provided in the embodiments of this application.
[0167] In some embodiments, the pen assembly 1 includes a pen body 11 with a through hole 111; the movable seat 4212 of the push rod 421 is provided with a positioning hole 42121; and the injection button 411 is provided with a positioning groove 41111.
[0168] The protective component 6 includes a safety pull ring 61, which has a limiting protrusion 611 and a limiting protrusion 612. The limiting protrusion 612 is located on the radial side of the limiting protrusion 611. The limiting protrusion 611 passes through the through hole 111 and into the positioning hole 42121 to lock the push rod 421. The limiting protrusion 612 is engaged in the positioning groove 41111 to lock the injection button 411.
[0169] Optionally, the safety pull ring 61 may also include a control handle 613. The control handle 613 has an anti-slip structure, such as grooves, which increases the contact area and friction to prevent slipping.
[0170] In this embodiment, the limiting protrusion 611 and the positioning hole 42121, as well as the limiting protrusion 612 and the positioning groove 41111, together constitute a precise locking and unlocking mechanism.
[0171] The protective component 6, particularly the safety pull ring 61, plays a central role in this mechanism. The safety pull ring 61 has a limiting protrusion 611 and a limiting protrusion 612, with the limiting protrusion 612 located radially to one side of the limiting protrusion 611. During locking, the limiting protrusion 611 passes through the through hole 111 in the pen body 11 and then inserts into the positioning hole 42121 of the push rod 421 movable seat 4212, thus locking the push rod 421. Additionally, the limiting protrusion 612 engages with the positioning groove 41111 of the injection button 411, locking the injection button 411.
[0172] When the safety pull ring 61 is locked, both the push rod 421 and the injection button 411 are fixed in place and cannot be operated, thus preventing accidental injection operations.
[0173] To unlock, the operator must first rotate the safety pull ring 61 to a certain position, causing the limiting protrusion 612 to disengage from the positioning groove 41111. Then, the operator pulls out the safety pull ring 61, causing the limiting protrusion 611 to disengage from the positioning hole 42121, thus releasing the push rod 421 and the injection button 411 and allowing them to resume their operational functions. This design not only ensures the safety of the device when not in use but also provides clear operating instructions for the operator, improving ease of use and accuracy.
[0174] Please refer to Figure 18 , Figure 18 A cross-sectional view of an ocular implant delivery device provided in an embodiment of this application.
[0175] like Figure 18 As shown, a front cone 12 is installed at the proximal end of the pen body 11, and a needle 2 protrudes from the front cone 12. An eye implant 3 is inside the needle 2. A cannula 7 is fitted over the outside of the pillow 2. When the pen cap 13 is connected to the front cone 12, the pen cap 13 abuts against the pen body 11. A safety pull ring 61 is installed on the pen body 11. The safety pull ring 61 locks the injection button 411 and the push rod 421. The needle retraction sleeve 51 protrudes from the distal end of the pen body 11.
[0176] This application also provides a method of using an ocular implant delivery device, applicable to the aforementioned ocular implant delivery device, the method of use including:
[0177] Step 1: Control the needle retraction mechanism 5 to retract the needle 2 into the pen assembly 1.
[0178] In this embodiment, the needle retraction mechanism 5 is controlled to safely retract the needle 2 into the pen assembly 1 to ensure the safety of the device when it is not in use and to facilitate storage.
[0179] In some embodiments, step one specifically includes:
[0180] Pull the operating cap 515 of the needle retraction sleeve 51 to control the needle retraction sleeve 51 to move away from the near end of the pen body 11. The gripper 511 of the needle retraction sleeve 51 drives the needle 2 to move synchronously, so that the needle tube 21 of the needle 2 retracts into the front cone 12 near the pen body, and further retracts into the pen body 11, thus realizing the needle retraction operation.
[0181] In this embodiment, step one of the method achieves the function of the needle retraction mechanism 5 through a specific operation: the operator needs to pull the operating cap 515 on the needle retraction sleeve 51, which will cause the needle retraction sleeve 51 to move away from the proximal end along the pen body 11. This action causes the gripper 511 inside the needle retraction sleeve 51 to drive the needle 2, so that the needle tube 21 of the needle 2 is guided back into the front cone 12 at the proximal end of the pen body, and finally retracted into the pen body 11. This process completes the needle retraction operation, ensuring proper storage of the needle and the safety of the entire device.
[0182] In some embodiments, the method of using the ocular implant delivery device further includes:
[0183] Step two: First, twist the safety pull ring 61 so that the limiting protrusion 612 of the safety pull ring 61 rotates out of the positioning groove 41111 of the injection button 411. Then, pull the safety pull ring 61 so that the limiting protrusion 611 of the safety pull ring 61 is pulled out from the positioning hole 42121 of the movable seat 4212, and further withdraws from the through hole 111 to be pulled out from the pen body 11, thus realizing the unlocking operation.
[0184] In this embodiment, the method of using the ocular implant delivery device further includes a second step, which is to unlock the injection mechanism 4 in preparation for the injection operation. Specifically, the second step first involves twisting the safety pull ring 61 so that the limiting protrusion 612 on it can disengage from the positioning groove 41111 of the injection button 411. This operation releases the locking state of the injection button 411.
[0185] Subsequently, the operator needs to pull the safety ring 61, which will cause the limiting protrusion 611 of the safety ring 61 to be pulled out from the positioning hole 42121 of the movable seat 4212 of the push rod 421. The removal of the limiting protrusion 611 means that the push rod 421 is also unlocked, ready for the injection action.
[0186] Finally, the safety ring 61 is pulled further until it is completely disengaged from the perforation 111 on the pen body 11. This action signifies that the injection mechanism 4 has been fully unlocked, and the device is now ready for injection. This series of actions ensures the safety and readiness of the operation.
[0187] It should be noted that many of the components mentioned in this application are general standard parts or components known to those skilled in the art, and their structure and principle can be learned by those skilled in the art through technical manuals or through conventional experimental methods.
[0188] It should be noted that in this specification, relational terms such as first and second are used only to distinguish one entity from several other entities, and do not necessarily require or imply any such actual relationship or order between these entities.
[0189] The above provides a detailed description of the ocular implant delivery device and its usage method provided in this application. Specific examples have been used to illustrate the principles and implementation methods of this application. The descriptions of the embodiments above are merely for the purpose of helping to understand the method and core ideas of this application. It should be noted that those skilled in the art can make various improvements and modifications to this application without departing from its principles, and these improvements and modifications also fall within the protection scope of the claims of this application.
Claims
1. An ocular implant delivery device, characterized in that include: Pen assembly; a needle, provided in the pen assembly, the needle being used to accommodate an ocular implant; an injection mechanism, provided in the pen assembly, the injection mechanism being used to push the ocular implant out of the needle to achieve delivery of the ocular implant; The needle retracting mechanism is arranged on the pen assembly, the needle retracting mechanism is connected to the needle head, and the needle retracting mechanism is used to control the needle head to be retracted into the pen assembly.
2. The ocular implant delivery device of claim 1, wherein: The needle head is provided with a connected needle tube and a connecting piece, the connecting piece is provided with a first connecting body and a second connecting body, the first connecting body is connected to the pen assembly, and the second connecting body is connected to the needle collection mechanism; When the needle retracting mechanism controls the movement of the needle, the force exerted by the pen assembly on the first connecting body is smaller than the force exerted by the needle retracting mechanism on the second connecting body.
3. The ocular implant delivery device of claim 2, wherein: The pen assembly comprises a front cone, which is provided with a through hole, a slide groove and a clamping groove; the needle collection mechanism comprises a needle collection sleeve, which is provided with a clamping claw; The needle tube passes through the through hole; The first connector includes a first protrusion and a second protrusion, the first protrusion cooperates with the slide slot, and the second protrusion cooperates with the clamping slot; The second connector includes a third protrusion, and the third protrusion cooperates with the clamping claw; When the needle retracting sleeve controls the needle tube to retract from the through hole to the front cone, the force acting on the second protrusion by the clamping groove is smaller than the force acting on the third protrusion by the clamping jaw.
4. The ocular implant delivery device of claim 3, wherein: The number of the third bumps is two, and the two third bumps are arranged at two ends of a first diagonal line of the connector, and the first bump and the second bump are arranged at two ends of a second diagonal line of the connector, and the first diagonal line and the second diagonal line are perpendicular.
5. The ocular implant delivery device of claim 3, wherein: The needle collection sleeve is also provided with an operating cap, which is located at the distal end of the pen assembly and is used to control the clamping claw to drive the needle to move.
6. The ocular implant delivery device of claim 5, wherein: The needle-retracting sleeve is also provided with a cylinder, the proximal end of the cylinder is connected to the clamping claw, the distal end of the cylinder is connected to the operating cap, and the cylinder is located in the pen assembly.
7. The ocular implant delivery device of claim 1, wherein: The injection mechanism comprises: A trigger assembly, provided on the pen assembly; An action component is arranged in the pen component, the action component is located in the needle collection mechanism, the action component can move in the needle collection mechanism, and the action component is used to push the eye implant out of the needle head under the control of the trigger component.
8. The ocular implant delivery device of claim 7, wherein: The needle collection mechanism comprises a needle collection sleeve, the needle collection sleeve is provided with a support arm, the support arm is provided with a clamping claw and a limiting portion; the action component is arranged in the needle collection sleeve, and the action component comprises: A push rod, provided with a connected ejector part and a movable seat, wherein the ejector part penetrates the needle head, the movable seat is arranged on the support arm, and the movable seat can move in the support arm, the distal end of the push rod is limited by the limiting part, and the moving range of the movable seat is limited by the clamping claw; The trigger assembly is used to control the ejector part to push the eye implant out of the needle head.
9. The ocular implant delivery device of claim 8, wherein: The push rod is also provided with a deformation mechanism, and the deformation mechanism is connected to the movable seat; the trigger assembly includes: An injection button is arranged on the pen assembly. By pressing the injection button to compress the deformation mechanism to deform, the ejector part pushes the eye implant out of the needle.
10. The ocular implant delivery device of claim 1, wherein: The needle head comprises a needle tube, and the needle tube is provided with a needle tube notch; the ocular implant delivery device further comprises: A sleeve is sleeved on the needle tube, and the position of the sleeve on the needle tube is adjustable; the sleeve is made of elastic material, and the sleeve wraps the notch of the needle tube. The sleeve enters the notch of the needle tube under the action of its own elasticity to fix the eye implant in the needle tube.
11. The ocular implant delivery device of claim 1, wherein: The pen assembly comprises: Pen body; A front cone, disposed at the proximal end of the pen cap; A pen cap, detachably connected to the pen body and / or the front cone; Wherein, the needle is arranged on the pen body, and the needle passes through the front cone.
12. The ocular implant delivery device of claim 11, wherein: The pen body is provided with an anti-slip structure; and / or, The pen body is provided with a special-shaped hole; the injection mechanism comprises an injection button, and the injection button is arranged in the special-shaped hole; and / or, The front cone is provided with a matching flange; the pen cap is interference-fitted with the matching flange.
13. The ocular implant delivery device of claim 1, wherein: Also includes: A protection component, disposed on the pen component, wherein the protection component is movable, and when the protection component moves to a first position, the injection mechanism is locked, and when the protection component moves to a second position, the injection mechanism is released; Wherein, the injection mechanism comprises an injection button and a push rod, and the objects locked and released by the protection component are the injection button and / or the push rod.
14. The ocular implant delivery device of claim 13, wherein: The pen assembly comprises a pen body with a perforation; a positioning hole is provided on the movable seat of the push rod; and a positioning groove is provided on the injection button; The protection component includes a safety pull ring, which is provided with a limiting boss and a limiting protrusion. The limiting protrusion is located on a radial side of the limiting boss. The limiting boss passes through the through hole and enters the positioning hole to lock the push rod, and the limiting protrusion is inserted into the positioning groove to lock the injection button.
15. A method of using an ocular implant delivery device, characterized in that: Applicable to the ocular implant delivery device according to any one of claims 1 to 14, the method of use comprising: Step 1: Control the needle collection mechanism to collect the needle into the pen assembly.
16. The method of using the ocular implant delivery device of claim 15, wherein: The step 1 specifically includes: Pull the operating cap of the needle collection sleeve to control the needle collection sleeve to move in the pen body in a direction away from the proximal end of the pen body. The clamping claw of the needle collection sleeve drives the needle to move synchronously, so that the needle tube of the needle is retracted into the front cone at the proximal end of the pen body and further retracted into the pen body to realize the needle collection operation.
17. The method of using the ocular implant delivery device of claim 15, wherein: Also includes: Step 2: First, twist the safety pull ring so that the limiting protrusion of the safety pull ring is rotated out of the positioning groove of the injection button. Then, pull the safety pull ring so that the limiting protrusion of the safety pull ring is pulled out of the positioning hole of the movable seat, and further withdraw it from the perforation and pull it out of the pen body to achieve the unlocking operation.
